Oxycontin and Capillary leak syndrome - a phase IV clinical study of FDA data

Summary:

Capillary leak syndrome is reported as a side effect among people who take Oxycontin (oxycodone hydrochloride), especially for people who are female, 50-59 old, have been taking the drug for < 1 month also take Herceptin, and have Depression.

The phase IV clinical study analyzes which people have Capillary leak syndrome when taking Oxycontin. It is created by eHealthMe based on reports of 210,595 people who have side effects when taking Oxycontin from the FDA, and is updated regularly.

What is Oxycontin?

Oxycontin has active ingredients of oxycodone hydrochloride. It is often used in pain. eHealthMe is studying from 212,533 Oxycontin users. Check the latest studies of Oxycontin.

What is Capillary leak syndrome?

Capillary leak syndrome (capillary leaks plasma) is found to be associated with 252 drugs and 421 conditions by eHealthMe. Check the latest studies of Capillary leak syndrome.

On Jul, 30, 2026

210,595 people reported to have side effects when taking Oxycontin.
Among them, 36 people (0.02%) have Capillary leak syndrome.

Could Oxycontin cause Capillary leak syndrome?

Among these 36 people:

How long have people been on Oxycontin when they have Capillary leak syndrome? *

What is the gender of people who have Capillary leak syndrome when taking Oxycontin? *

female: 80 %
male: 20 %

What is the age of people who have Capillary leak syndrome when taking Oxycontin? *

What are other drugs people take besides Oxycontin? *

What are other side effects people have besides Capillary leak syndrome? *

Anaemia (lack of blood): 26 people, 72.22%
Swelling: 26 people, 72.22%
Rashes (redness): 26 people, 72.22%
Gingival Disorder (gum disease): 25 people, 69.44%
Impaired Healing: 25 people, 69.44%
Bone Swelling: 25 people, 69.44%
Pain In Jaw: 25 people, 69.44%
Pathological Fracture (broken bone caused by disease): 25 people, 69.44%
Metastases To Lung (cancer spreads to lung): 25 people, 69.44%
Pleural Effusion (water on the lungs): 25 people, 69.44%

What are the existing conditions these people have? *

Metastases To Bone (cancer spreads to bone): 25 people, 69.44%
Breast Cancer: 25 people, 69.44%
Metastasis (spreadable cancer to other organ from origin): 25 people, 69.44%
Depression: 25 people, 69.44%
Oedema (fluid collection in tissue): 16 people, 44.44%
Hereditary Neuropathic Amyloidosis (hereditary- diseases resulting from abnormal deposition of certain proteins (amyloid) in various bodily areas by problems with signals from the nerves): 5 people, 13.89%
Type 2 Diabetes: 5 people, 13.89%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 5 people, 13.89%
Carotid Arteriosclerosis (plaque deposition in artery): 5 people, 13.89%
Pancreatic Carcinoma (pancreatic cancer): 2 people, 5.56%

* Approximation only. Some reports may have incomplete information.

Do you take Oxycontin and have Capillary leak syndrome?

- Check whether Capillary leak syndrome is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Oxycontin:

Oxycontin (212,533 reports)

Browse all side effects of Oxycontin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Capillary leak syndrome:

Capillary leak syndrome (252 drugs)

Browse all the conditions that are associated with Capillary leak syndrome:

Capillary leak syndrome (421 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on oxycodone hydrochloride (the active ingredients of Oxycontin) and Oxycontin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.